Jack A. Khattar

President, CEO

Jack A. Khattar (President, CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in SUPN. The largest single filing was $1.8M of SUPN (34,880 sh across 2 lots, as filed), executed Mar 13. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.8M

shares × price, as filed

Last traded

Mar 13

Filed Mar 16

Open performance→

Volume by month

Buys $0 Sells $20.0M

Shares × price, as filed · by filing month · past 24 months

Most traded names

SUPN SUPN 0 buys · 13 sells 13 filings

Recent filings

SUPNSALE SUPERNUS PHARMACEUTICALS, INC. View filing → $1.8M
34,880 sh across 2 lots
Exec Mar 13
Filed Mar 16 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. View filing → $3.0M
58,371 sh × $50.55
Exec Oct 9 2025
Filed Oct 10 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. View filing → $1.9M
40,173 sh × $48.07
Exec Oct 1 2025
Filed Oct 2 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. View filing → $414K
8,588 sh × $48.25
Exec Sep 30 2025
Filed Oct 1 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. View filing → $491K
10,235 sh × $48.02
Exec Sep 29 2025
Filed Sep 30 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. View filing → $1.4M
29,513 sh × $47.23
Exec Sep 23 2025
Filed Sep 24 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. View filing → $780K
16,587 sh × $47.02
Exec Sep 22 2025
Filed Sep 23 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. View filing → $293K
6,322 sh × $46.29
Exec Sep 8 2025
Filed Sep 9 2025 · 5:30 PM ET More filings →